ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

36,398Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 5176

$2M Total Retail Price of All Prescriptions

Rank: 53 out of 5176

719 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

23% of this provider’s 719 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

2% of this provider’s 719 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 28,811 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 3,049 2,327 1 1
METOPROLOL TARTRATE 2,202 1,731 10 2 6
AMLODIPINE BESYLATE 1,913 1,551 3 2
LISINOPRIL 1,454 1,115 4 5
LEVOTHYROXINE SODIUM 1,119 920 5 4
METFORMIN HCL 905 641 6 7
FUROSEMIDE 704 573 7 8
LACTULOSE 678 510 8 87
CLOBETASOL PROPIONATE 643 511 9 130
ADVAIR DISKUS 561 453 10 32
EXELON 559 525 11 162
WARFARIN SODIUM 544 489 12 13
TAMSULOSIN HCL 543 468 13 20
OMEPRAZOLE 533 386 14 3
GLIPIZIDE 518 422 15 63
RANITIDINE HCL 471 379 16 36
OXYCODONE-ACETAMINOPHEN 434 316 S2 17 101
METOPROLOL SUCCINATE 429 341 18 11
GABAPENTIN 399 340 19 21
MIRTAZAPINE 391 367 20 45
LOSARTAN POTASSIUM 389 325 21 14
NAMENDA 374 361 22 47
FINASTERIDE 367 342 23 69
ALBUTEROL SULFATE 338 306 24 99
CLOPIDOGREL 293 253 25 26
CITALOPRAM HBR 273 251 26 31
DIVALPROEX SODIUM 268 238 27 104
JANUVIA 251 192 28 25
CARVEDILOL 249 200 29 24
SPIRIVA 241 234 30 54
FENTANYL 232 161 S2 31 172
HYDROCHLOROTHIAZIDE 229 158 32 10
GLIPIZIDE XL 229 170 32 83
NOVOLIN 70-30 229 161 32 287
FLUTICASONE PROPIONATE 220 145 35 38
NYSTATIN-TRIAMCINOLONE 219 194 36 142
PLAVIX 218 197 37 29
SERTRALINE HCL 216 201 38 30
QUETIAPINE FUMARATE 206 173 39 75
NOVOLIN R 203 131 40 191
DIGOXIN 195 193 41 56
LEVETIRACETAM 194 135 42 92
ATORVASTATIN CALCIUM 191 109 43 9
CARBIDOPA-LEVODOPA 188 171 44 98
LISINOPRIL-HYDROCHLOROTHIAZIDE 181 93 45 49
CLOTRIMAZOLE 181 162 45 296
ATENOLOL 169 162 47 12
DOXAZOSIN MESYLATE 168 116 48 103
SINGULAIR 167 134 49 62
POTASSIUM CHLORIDE 157 136 50 34
CLOTRIMAZOLE-BETAMETHASONE 154 116 51 94
LOSARTAN-HYDROCHLOROTHIAZIDE 149 129 52 35
ISOSORBIDE MONONITRATE ER 148 134 53 44
IPRATROPIUM BROMIDE 143 121 54 135
PREDNISONE 142 120 55 52
FLUOCINONIDE 140 120 56 165
ALENDRONATE SODIUM 139 113 57 18
VALPROIC ACID 137 123 58 195
AZITHROMYCIN 136 112 59 42
DIOVAN 136 130 59 19
RISPERIDONE 133 108 61 78
NAPROXEN 130 96 62 95
MUPIROCIN 127 109 63 182
GLIPIZIDE ER 123 88 64 117
LOVASTATIN 122 90 65 46
TRAZODONE HCL 122 88 65 71
METOCLOPRAMIDE HCL 121 88 67 176
METOLAZONE 121 100 67 271
LATANOPROST 119 105 69 185
HYDRALAZINE HCL 118 95 70 73
ZOLPIDEM TARTRATE 116 108 71 17
TRAVATAN Z 115 108 72 234
SEROQUEL 113 106 73 166
POLYETHYLENE GLYCOL 3350 112 84 74 74
NOVOLOG MIX 70-30 FLEXPEN 112 81 74 290
EURAX 108 89 10 76 604
BRIMONIDINE TARTRATE 108 85 76 244
CLONIDINE HCL 107 77 78 79
TRICOR 106 71 79 148
SPIRONOLACTONE 104 93 80 88
LIPITOR 104 68 80 51
INSULIN SYRINGE 103 70 82 137
PHENYTOIN SODIUM EXTENDED 103 22 82 232
MONTELUKAST SODIUM 101 85 84 123
ENABLEX 99 73 85 284
AVODART 98 85 86 107
PRADAXA 98 78 86 192
CIPROFLOXACIN HCL 98 76 86 84
AMOX TR-POTASSIUM CLAVULANATE 97 78 89 141
ESCITALOPRAM OXALATE 97 97 89 89
KETOCONAZOLE 97 78 89 233
OXYBUTYNIN CHLORIDE 94 78 92 227
LANTUS 94 82 92 66
ISOSORBIDE DINITRATE 91 53 94 288
SANTYL 90 88 95 124
PROCTOZONE-HC 89 78 96 171
LEVOFLOXACIN 88 70 97 109
NIFEDIPINE ER 85 41 98 48
ROPINIROLE HCL 83 82 99 208
CILOSTAZOL 83 67 99 206
PERMETHRIN 80 70 101 355
LAMOTRIGINE 79 28 102 289
BENZTROPINE MESYLATE 78 43 R 103 201
OXYBUTYNIN CHLORIDE ER 78 66 103 204
ZETIA 75 62 105 68
HYDROMORPHONE HCL 75 67 S2 105 382
VENTOLIN HFA 74 52 107 64
DIOVAN HCT 74 53 107 39
PROAIR HFA 71 30 109 60
NOVOFINE AUTOCOVER 71 44 109 484
ALLOPURINOL 71 49 109 41
CALCIUM ACETATE 67 49 112 336
CEFUROXIME 65 52 113 273
OLANZAPINE 64 61 114 140
NEXIUM 64 44 114 16
MECLIZINE HCL 60 37 116 81
HYDROCODONE-ACETAMINOPHEN 60 44 S3 116 27
AMITRIPTYLINE HCL 59 43 R 118 177
CARBAMAZEPINE 58 36 119 302
DETROL LA 56 47 120 249
CHLORHEXIDINE GLUCONATE 54 29 121 202
FLUCONAZOLE 53 40 122 428
HALOPERIDOL 53 34 122 145
PREDNISOLONE ACETATE 51 49 124 538
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.